Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02609776 |
|---|---|
| Brief Title: | Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer (CHRYSALIS) |
| First Submitted : | November 18, 2015 |
| First Submitted that Met QC Criteria : | November 18, 2015 |
| First Posted : | November 20, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 25, 2024 |